Pfizer's CEO says he's got a plan to deal with Trump's tariffs — move overseas drug manufacturing to the US
"I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of President Donald Trump's ...
Pfizer's Direct-To-Consumer Model Faces Scrutiny From US Senators (UPDATED)
This article has been updated to include a statement from UpScriptHealth. In August 2024, Pfizer Inc (NYSE:PFE) introduced ...
Pfizer CEO says he's prepared to shift manufacturing to the U.S. amid tariff threats
CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if ...
Pfizer could use existing US manufacturing to counter potential tariff hit
Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the United ...
Life Science Leader13d
A CEO With A General Counsel's Perspective
LB Pharmaceuticals CEO Heather Turner explains why 18 years as a general counsel provided her with an advantageous ...
PharmExec7d
Insights on UpScriptHealth’s Recent Pfizer Partnership & Its Impact on Drug Access
In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, describes how his company's ...
Fierce Biotech2d
Pfizer, Arvinas post mixed breast cancer survival results in first phase 3 test for a PROTAC degrader
The drug in question, called vepdegestrant, is an oral PROteolysis TArgeting Chimera (PROTAC) ER degrader. The phase 3 study ...
Business Insider9d
Pfizer's CEO says he's got a plan to deal with Trump's tariffs — move overseas drug manufacturing to the US
An icon in the shape of a lightning bolt. Impact Link Albert Bourla, Pfizer's CEO, said on Monday that the company may move overseas drug manufacturing back to the US if President Donald Trump's ...